In a measure that flouts the FDA, Florida says doctors can give unapproved stem-cell therapies for wound care, pain ...

Around 10 million people globally live with the life-threatening virus HTLV-1. Yet it remains a poorly understood disease ...

In a recent landmark study, scientists have unveiled how HIV-1 penetrates the cell's nuclear barrier—a discovery that could reshape antiviral strategies. The research, led by Professor Peijun Zhang, ...

Semaglutide has surged in popularity over the past two years, thanks to its remarkable effectiveness as a long-acting GLP-1 ...

Psilocybin's health benefits could extend beyond the mental realm. A new study in human cells and mice has found the first ...

Around 10 million people globally live with the life-threatening virus HTLV-1. Yet it remains a poorly understood disease that currently has no preventative treatments and no cure.

The new drug forces fat cells to produce more energy and doesn't impact appetite or muscle mass, unlike some existing ...

Now, an ambitious Microsoft-funded project at the University of California, San Diego (UCSD), is studying the neural activity ...

Pancreatic cancer continues to pose one of the greatest challenges in global cancer treatment. Known for its aggressive ...

The first human-tested weight-loss drug that burns calories through creatine-based heat generation, without reducing appetite, has successfully completed its Phase I trial.

S.BIOMEDICS announced encouraging one-year post-transplant results from Phase 1/2a clinical trial evaluating A9-DPC cell therapy for Parkinson's disease. The data demonstrate a favorable safety and ...

Vir Biotech begins patient dosing in phase 1 trial of EGFR-targeting PRO-XTEN dual-masked T-cell engager VIR-5525 to treat solid tumours: San Francisco Saturday, July 26, 2025, 12 ...